Alector ( NASDAQ:ALEC ) Full Year 2024 Results Key Financial Results Revenue: US$100.6m (up 3.6% from FY 2023). Net... Alector Inc (ALEC) reports significant growth in collaboration revenue and ...

And the first IPO without a fixed share price since the shutdown ended late last month was from Alector, a biotech that is aiming to find new treatments for dementia. Alector fell on its trading ...

Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company’s lead product ...

After hours: March 19 at 6:23:08 PM EDT Loading Chart for DTIL ...